Source:http://linkedlifedata.com/resource/pubmed/id/15640338
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-1-10
|
pubmed:abstractText |
It is now established that an excessive and sustained mobilisation of neutrophils is a hallmark of several chronic inflammatory lung disorders, including severe obstructive lung disease. This article reviews evidence that the cytokine interleukin (IL)-17A is a major orchestrator of sustained neutrophilic mobilisation. Current evidence suggests that IL-17A is produced by T-lymphocytes, and that it exerts an orchestrating effect on the accumulation and associated activity of neutrophils in the bronchoalveolar space indirectly, through an induced release of specific cytokines and colony-stimulating factors in resident lung cells. Although the involvement of IL-17A in inflammatory lung disorders is supported by several recent studies, its causative role is still uncertain. However, the unique position of interleukin-17A at the interface between acquired and innate immunity puts this cytokine forward as an important signal for the reinforcement of host defence; it also implies that interleukin-17A may constitute a useful target for pharmacotherapeutic intervention.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-72
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15640338-Biological Markers,
pubmed-meshheading:15640338-Cytokines,
pubmed-meshheading:15640338-Female,
pubmed-meshheading:15640338-Humans,
pubmed-meshheading:15640338-Immunity, Innate,
pubmed-meshheading:15640338-Interleukin-17,
pubmed-meshheading:15640338-Lung Diseases,
pubmed-meshheading:15640338-Lymphocyte Activation,
pubmed-meshheading:15640338-Male,
pubmed-meshheading:15640338-Neutrophils,
pubmed-meshheading:15640338-Prognosis,
pubmed-meshheading:15640338-Risk Factors,
pubmed-meshheading:15640338-Sensitivity and Specificity,
pubmed-meshheading:15640338-Severity of Illness Index,
pubmed-meshheading:15640338-T-Lymphocytes
|
pubmed:year |
2005
|
pubmed:articleTitle |
Neutrophils, interleukin-17A and lung disease.
|
pubmed:affiliation |
Cooperative Research Centre for Chronic Inflammatory Diseases, Dept of Pharmacology, The University of Melbourne, Medical Building, Level 8, W810, Grattan Street/Royal Parade, Parkville, VIC 3010, Australia. a.linden@unimelb.edu.au
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review,
Research Support, Non-U.S. Gov't
|